Transmembrane Protein-Based Risk Model and H3K4me3 Modification Characteristics in Lung Adenocarcinoma
出版年份 2022 全文链接
标题
Transmembrane Protein-Based Risk Model and H3K4me3 Modification Characteristics in Lung Adenocarcinoma
作者
关键词
-
出版物
Frontiers in Oncology
Volume 12, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2022-03-29
DOI
10.3389/fonc.2022.828814
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Immune signature-based risk stratification and prediction of immune checkpoint inhibitor’s efficacy for lung adenocarcinoma
- (2021) Ming Yi et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Loss of type I IFN responsiveness impairs natural killer cell antitumor activity in breast cancer
- (2021) Damien J. Zanker et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- TMEM106C contributes to the malignant characteristics and poor prognosis of hepatocellular carcinoma
- (2021) Jicheng Duan et al. Aging-US
- 5‐Fluorouracil efficacy requires anti‐tumor immunity triggered by cancer‐cell‐intrinsic STING
- (2021) Jingru Tian et al. EMBO JOURNAL
- LY6K-AS lncRNA is a lung adenocarcinoma prognostic biomarker and regulator of mitotic progression
- (2021) Mohamad Moustafa Ali et al. ONCOGENE
- Effects of Hypoxia in Intestinal Tumors on Immune Cell Behavior in the Tumor Microenvironment
- (2021) Luping Zhang et al. Frontiers in Immunology
- Activation of MAT2A-RIP1 signaling axis reprograms monocytes in gastric cancer
- (2021) Yan Zhang et al. Journal for ImmunoTherapy of Cancer
- Metformin Reduces Histone H3K4me3 at the Promoter Regions of Positive Cell Cycle Regulatory Genes in Lung Cancer Cells
- (2021) Dongho Kim et al. Cancers
- Comprehensive Analysis of the Immune and Prognostic Implication of COL6A6 in Lung Adenocarcinoma
- (2021) Yi Ma et al. Frontiers in Oncology
- KDM5 inhibition offers a novel therapeutic strategy for the treatment of KMT2D mutant lymphomas
- (2021) James Andrew Heward et al. BLOOD
- Chemokines and the immune response to cancer
- (2021) Aleksandra J. Ozga et al. IMMUNITY
- The STING phase-separator suppresses innate immune signalling
- (2021) Xiaoyu Yu et al. NATURE CELL BIOLOGY
- The tumor suppressor kinase DAPK3 drives tumor-intrinsic immunity through the STING–IFN-β pathway
- (2021) Mariko Takahashi et al. NATURE IMMUNOLOGY
- TBK1 recruitment to STING activates both IRF3 and NF-κB that mediate immune defense against tumors and viral infections
- (2021) Seoyun Yum et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- TMEM70 and TMEM242 help to assemble the rotor ring of human ATP synthase and interact with assembly factors for complex I
- (2021) Joe Carroll et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Development of Immunotherapy Combination Strategies in Cancer
- (2021) Timothy A. Yap et al. Cancer Discovery
- Radiotherapy to Enhance Chimeric Antigen Receptor T-Cell Therapeutic Efficacy in Solid Tumors
- (2021) Franziska Hauth et al. JAMA Oncology
- Analysis of immune-related signatures of lung adenocarcinoma identified two distinct subtypes: implications for immune checkpoint blockade therapy
- (2020) Qinghua Wang et al. Aging-US
- STING Pathway Expression Identifies NSCLC With an Immune-Responsive Phenotype
- (2020) Carminia M. Della Corte et al. Journal of Thoracic Oncology
- Profile of Histone H3 Lysine 4 Trimethylation and the Effect of Lipopolysaccharide/Immune Complex-Activated Macrophages on Endotoxemia
- (2020) Vichaya Ruenjaiman et al. Frontiers in Immunology
- Ribonucleotide reductase small subunit M2 is a master driver of aggressive prostate cancer
- (2020) Ying Z. Mazzu et al. Molecular Oncology
- Uncoupling histone H3K4 trimethylation from developmental gene expression via an equilibrium of COMPASS, Polycomb and DNA methylation
- (2020) Delphine Douillet et al. NATURE GENETICS
- TP53 mutations in myelodysplastic syndromes and secondary AML confer an immunosuppressive phenotype
- (2020) David A. Sallman et al. BLOOD
- Telomere Stress Potentiates STING-Dependent Anti-tumor Immunity
- (2020) Ilgen Mender et al. CANCER CELL
- Integrated analysis of single-cell RNA-seq and bulk RNA-seq unravels tumour heterogeneity plus M2-like tumour-associated macrophage infiltration and aggressiveness in TNBC
- (2020) Xuanwen Bao et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- E2F1‐activated SPIN1 promotes tumor growth via a MDM2‐p21‐E2F1 feedback loop in gastric cancer
- (2020) Bei‐bei Lv et al. Molecular Oncology
- CXCR3 and Cognate Ligands are Associated with Immune Cell Alteration and Aggressiveness of Pancreatic Ductal Adenocarcinoma
- (2020) Andrew Cannon et al. CLINICAL CANCER RESEARCH
- An H3K4me3 reader, BAP18 as an adaptor of COMPASS-like core subunits co-activates ERα action and associates with the sensitivity of antiestrogen in breast cancer
- (2020) Ge Sun et al. NUCLEIC ACIDS RESEARCH
- Histone 3 lysine-27 demethylase KDM6A coordinates with KMT2B to play an oncogenic role in NSCLC by regulating H3K4me3
- (2020) Xuejiao Leng et al. ONCOGENE
- Polymorphisms in STING Affect Human Innate Immune Responses to Poxviruses
- (2020) Richard B. Kennedy et al. Frontiers in Immunology
- Transmembrane (TMEM) protein family members: Poorly characterized even if essential for the metastatic process
- (2019) Sébastien Marx et al. SEMINARS IN CANCER BIOLOGY
- Outcomes to first-line pembrolizumab in patients with non-small-cell lung cancer and very high PD-L1 expression
- (2019) E J Aguilar et al. ANNALS OF ONCOLOGY
- Immune effector monocyte–neutrophil cooperation induced by the primary tumor prevents metastatic progression of breast cancer
- (2019) Catharina Hagerling et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The Cytosolic DNA-Sensing cGAS–STING Pathway in Cancer
- (2019) John Kwon et al. Cancer Discovery
- A G3BP1-interacting lncRNA promotes ferroptosis and apoptosis in cancer via nuclear sequestration of p53
- (2018) Chao Mao et al. CANCER RESEARCH
- Indoleamine 2,3-dioxygenase 1 and programmed cell death-ligand 1 co-expression correlates with aggressive features in lung adenocarcinoma
- (2018) Yuka Kozuma et al. EUROPEAN JOURNAL OF CANCER
- Nivolumab plus Ipilimumab in Lung Cancer with a High Tumor Mutational Burden
- (2018) Matthew D. Hellmann et al. NEW ENGLAND JOURNAL OF MEDICINE
- Epacadostat Plus Pembrolizumab in Patients With Advanced Solid Tumors: Phase I Results From a Multicenter, Open-Label Phase I/II Trial (ECHO-202/KEYNOTE-037)
- (2018) Tara C. Mitchell et al. JOURNAL OF CLINICAL ONCOLOGY
- Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response
- (2018) Peng Jiang et al. NATURE MEDICINE
- Differential expression of PD-L1 and IDO1 in association with the immune microenvironment in resected lung adenocarcinomas
- (2018) M. Lisa Zhang et al. MODERN PATHOLOGY
- The STAT4/MLL1 Epigenetic Axis Regulates the Antimicrobial Functions of Murine Macrophages
- (2017) William F. Carson et al. JOURNAL OF IMMUNOLOGY
- Histone Methyltransferase SET8 Epigenetically Reprograms Host Immune Responses to Assist Mycobacterial Survival
- (2017) Vikas Singh et al. JOURNAL OF INFECTIOUS DISEASES
- Cancer statistics in China, 2015
- (2016) Wanqing Chen et al. CA-A CANCER JOURNAL FOR CLINICIANS
- An Aggressive Subtype of Stage I Lung Adenocarcinoma with Molecular and Prognostic Characteristics Typical of Advanced Lung Cancers
- (2016) Elisa Dama et al. CLINICAL CANCER RESEARCH
- Robust enumeration of cell subsets from tissue expression profiles
- (2015) Aaron M Newman et al. NATURE METHODS
- Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer
- (2012) Suzanne L. Topalian et al. NEW ENGLAND JOURNAL OF MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now